Skyline Venture Partners Qualified Purchaser Fund Iv L P Insider Trades

Insider Trading History

Track insider trading activity for Skyline Venture Partners Qualified Purchaser Fund Iv L P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$870M 2,173,913 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$937M 2,341,664 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $6.28M 1,488,968 shares
Last Trade
Oct 27, 2014 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$48.7M 121,760 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $5.77M 1,367,208 shares
Last Trade
Oct 27, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$467M 1,167,208 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (In The Money)Reported as In The Money on SEC Form 4.
$48.7M 121,760 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.57B 3,932,747 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$975M 2,436,437 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $6.05M 1,432,930 shares
Last Trade
Oct 27, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.4M 56,038 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2B 5,000,000 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 27, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$556M 1,389,064 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $844k 200,000 shares
Last Trade
Oct 27, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$80M 200,000 shares
$400.00
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Protara Therapeutics
Protara Therapeutics TARA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 21, 2014 Sale
No data
No data
$4.22
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Holding Value $2.47M 2,871,933 shares
Last Trade
Mar 07, 2014 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$310M 1,300,000 shares
$238.40
$0.86
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
10% owner
Holding Value $0 0 shares
Last Trade
Feb 20, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$42M 3,000,000 shares
$14.01
$8.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up